Breaking News Instant updates and real-time market news.

MIMZF

Nighthawk Gold

/

+

08:18
09/01/22
09/01
08:18
09/01/22
08:18

Nighthawk report additional drill assay results from 2022 exploration program

Nighthawk Gold reports additional drill assay results from its 2022 Exploration Program, with results from the Grizzly Bear Deposit and 24 and 27 Deposits within the Colomac Centre Area. Nighthawk President & CEO Keyvan Salehi commented, "The latest drill results, combined with results released previously from Grizzly Bear and 24/27 Deposits, demonstrate the immense potential for mineral resource expansion within the Colomac Centre."

OTHER BREAKING NEWS FROM THE FLY

Conference/Events
JPMorgan REITs analyst to hold an analyst/industry conference call » 10:38
12/01/22
12/01
10:38
12/01/22
10:38

REITs Analyst Streeter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
Week of 11/25 EIA natural gas report 81bcf  10:37
12/01/22
12/01
10:37
12/01/22
10:37
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
American International's EPIQ Scripts obtains CSR from U.S. DEA » 10:36
12/01/22
12/01
10:36
12/01/22
10:36
AMIH

American International Holdings

/

+

American International…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMIH American International Holdings
/

+

Options
Citi put volume heavy and directionally bearish » 10:35
12/01/22
12/01
10:35
12/01/22
10:35
C

Citi

$47.51 /

-0.89 (-1.84%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
C Citi
$47.51 /

-0.89 (-1.84%)

C Citi
$47.51 /

-0.89 (-1.84%)

11/23/22 Keefe Bruyette
Citi only bank with living will issues, says Keefe Bruyette
11/02/22 JPMorgan
Citi price target raised to $49.50 from $49 at JPMorgan
10/17/22 BMO Capital
Citi price target lowered to $71 from $76 at BMO Capital
10/17/22 Barclays
Citi price target lowered to $57 from $64 at Barclays
C Citi
$47.51 /

-0.89 (-1.84%)

C Citi
$47.51 /

-0.89 (-1.84%)

C Citi
$47.51 /

-0.89 (-1.84%)

C Citi
$47.51 /

-0.89 (-1.84%)

Conference/Events
JPMorgan utilities analyst to hold an analyst/industry conference call » 10:32
12/01/22
12/01
10:32
12/01/22
10:32

Analyst Kwan discusses…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

General news
EIA natural gas storage change for week ending November 25 » 10:30
12/01/22
12/01
10:30
12/01/22
10:30
USO

United States Oil Fund

$72.09 /

+1.86 (+2.65%)

Gas inventories were…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
USO United States Oil Fund
$72.09 /

+1.86 (+2.65%)

USO United States Oil Fund
$72.09 /

+1.86 (+2.65%)

USO United States Oil Fund
$72.09 /

+1.86 (+2.65%)

General news
The U.S. ISM drop » 10:30
12/01/22
12/01
10:30
12/01/22
10:30
$ECON

Economic Data

/

+

The U.S. ISM drop to a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Starwood Waypoint Homes trading halted, volatility trading pause  10:28
12/01/22
12/01
10:28
12/01/22
10:28
SFR

Appreciate

$6.29 /

-0.23 (-3.53%)

 
ShowHide Related Items >><<
SFR Appreciate
$6.29 /

-0.23 (-3.53%)

SFR Appreciate
$6.29 /

-0.23 (-3.53%)

10/17/22 DA Davidson
PropTech Investment Corporation II initiated with a Buy at DA Davidson
Conference/Events
JPMorgan financial analysts to hold analyst/industry conference call » 10:27
12/01/22
12/01
10:27
12/01/22
10:27

Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Carnival call volume above normal and directionally bullish » 10:25
12/01/22
12/01
10:25
12/01/22
10:25
CCL

Carnival

$10.17 /

+0.24 (+2.42%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCL Carnival
$10.17 /

+0.24 (+2.42%)

CCL Carnival
$10.17 /

+0.24 (+2.42%)

11/17/22 Credit Suisse
Norwegian Cruise downgraded to Underperform from Outperform at Credit Suisse
11/14/22 UBS
Carnival price target raised to $16 from $8 at UBS
10/27/22 Tigress Financial
Tigress Financial sees 45% 12-month upside in Carnival shares
10/12/22 UBS
Carnival price target lowered to $8 from $11 at UBS
CCL Carnival
$10.17 /

+0.24 (+2.42%)

  • 21
    Jul
CCL Carnival
$10.17 /

+0.24 (+2.42%)

CCL Carnival
$10.17 /

+0.24 (+2.42%)

CCL Carnival
$10.17 /

+0.24 (+2.42%)

General news
U.S. construction spending declined 0.3% in October » 10:25
12/01/22
12/01
10:25
12/01/22
10:25
$ECON

Economic Data

/

+

U.S. construction…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Conference/Events
Oppenheimer emerging biotech analysts to hold analyst/industry conference call » 10:25
12/01/22
12/01
10:25
12/01/22
10:25
ACET

Adicet Bio

$18.31 /

+0.12 (+0.66%)

, ACLX

Arcellx

$20.08 /

+0.12 (+0.60%)

, ALLO

Allogene Therapeutics

$9.46 /

-0.38 (-3.86%)

, BMY

Bristol-Myers

$80.52 /

+0.33 (+0.41%)

, CELU

Celularity

$1.78 /

+0.08 (+4.71%)

, CLLS

Cellectis

$2.22 /

+0.01 (+0.45%)

, CRBU

Caribou Biosciences

$9.18 /

-0.145 (-1.55%)

, CRSP

Crispr Therapeutics

$54.83 /

+0.04 (+0.07%)

, DTIL

Precision BioSciences

$1.37 /

+0.01 (+0.74%)

, FATE

Fate Therapeutics

$20.93 /

+0.1 (+0.48%)

, GILD

Gilead

$88.72 /

+0.87 (+0.99%)

, GRCL

Gracell

$3.32 /

+0.07 (+2.15%)

, IPSC

Century Therapeutics

$10.45 /

-0.02 (-0.19%)

, JNJ

Johnson & Johnson

$178.00 /

+0.03 (+0.02%)

, LEGN

Legend Biotech

$51.29 /

-0.035 (-0.07%)

, MBIO

Mustang Bio

/

+

, NKTX

Nkarta

$8.43 /

-0.03 (-0.35%)

, PSTX

Poseida Therapeutics

$4.63 /

+0.09 (+1.98%)

Emerging Biotechnology…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACET Adicet Bio
$18.31 /

+0.12 (+0.66%)

ACLX Arcellx
$20.08 /

+0.12 (+0.60%)

ALLO Allogene Therapeutics
$9.46 /

-0.38 (-3.86%)

BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

CELU Celularity
$1.78 /

+0.08 (+4.71%)

CLLS Cellectis
$2.22 /

+0.01 (+0.45%)

CRBU Caribou Biosciences
$9.18 /

-0.145 (-1.55%)

CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

DTIL Precision BioSciences
$1.37 /

+0.01 (+0.74%)

FATE Fate Therapeutics
$20.93 /

+0.1 (+0.48%)

GILD Gilead
$88.72 /

+0.87 (+0.99%)

GRCL Gracell
$3.32 /

+0.07 (+2.15%)

IPSC Century Therapeutics
$10.45 /

-0.02 (-0.19%)

JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

LEGN Legend Biotech
$51.29 /

-0.035 (-0.07%)

MBIO Mustang Bio
/

+

NKTX Nkarta
$8.43 /

-0.03 (-0.35%)

PSTX Poseida Therapeutics
$4.63 /

+0.09 (+1.98%)

ACET Adicet Bio
$18.31 /

+0.12 (+0.66%)

09/21/22 JPMorgan
Adicet Bio initiated with Overweight, $23 target at JPMorgan
09/21/22 JPMorgan
Adicet Bio initiated with an Overweight at JPMorgan
03/30/22 SMBC Nikko
Adicet Bio initiated with an Outperform at SMBC Nikko
03/17/22 JMP Securities
Adicet Bio price target lowered to $21 from $30 at JMP Securities
ACLX Arcellx
$20.08 /

+0.12 (+0.60%)

10/31/22 Guggenheim
Arcellx initiated with a Buy at Guggenheim
10/27/22 Needham
Arcellx initiated with a Buy at Needham
07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
07/20/22 Canaccord
Arcellx initiated with a Buy at Canaccord
ALLO Allogene Therapeutics
$9.46 /

-0.38 (-3.86%)

11/21/22 H.C. Wainwright
Allogene Therapeutics price target lowered to $29 from $43 at H.C. Wainwright
09/22/22 B. Riley
Allogene Therapeutics price target lowered to $18 from $21 at B. Riley
09/20/22 B. Riley
B. Riley replaces Allogene with Syndax as top pick for 2022
08/10/22 Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

11/17/22 Credit Suisse
Bristol-Myers initiated with a Neutral at Credit Suisse
11/17/22 Morgan Stanley
Ventyx Biosciences initiated with an Overweight at Morgan Stanley
11/14/22 BMO Capital
CytomX Therapeutics downgraded to Market Perform from Outperform at BMO Capital
11/02/22 Evercore ISI
Evercore starts Legend Biotech with an Outperform on Carvykti potential
CELU Celularity
$1.78 /

+0.08 (+4.71%)

08/25/22 Alliance Global Partners
Celularity initiated with a Buy at Alliance Global Partners
08/23/22 Truist
Celularity price target lowered to $6 from $10 at Truist
06/22/22 H.C. Wainwright
Celularity initiated with a Buy at H.C. Wainwright
04/06/22 Truist
Celularity downgraded to Hold from Buy at Truist
CLLS Cellectis
$2.22 /

+0.01 (+0.45%)

08/18/22 Citi
Cellectis price target raised to $36 from $34 at Citi
05/18/22 Baird
Cellectis upgraded to Outperform at Baird on valuation 'backstop'
05/18/22 Baird
Cellectis upgraded to Outperform from Neutral at Baird
05/13/22 Barclays
Cellectis price target lowered to $7 from $9 at Barclays
CRBU Caribou Biosciences
$9.18 /

-0.145 (-1.55%)

11/23/22 Citi
Caribou Biosciences price target lowered to $37 from $38 at Citi
08/29/22 Citi
Caribou Biosciences price target lowered to $38 from $39 at Citi
08/18/22 H.C. Wainwright
Caribou Biosciences price target lowered to $27 from $28 at H.C. Wainwright
05/12/22 Citi
Caribou Biosciences price target raised to $39 from $29 at Citi
CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

11/23/22 Citi
Crispr Therapeutics price target lowered to $63 from $83 at Citi
11/02/22 Barclays
Crispr Therapeutics price target lowered to $61 from $88 at Barclays
11/02/22 Credit Suisse
Crispr Therapeutics price target lowered to $78 from $90 at Credit Suisse
10/11/22 Morgan Stanley
Crispr Therapeutics initiated with an Underweight at Morgan Stanley
DTIL Precision BioSciences
$1.37 /

+0.01 (+0.74%)

11/10/22 H.C. Wainwright
Precision BioSciences price target lowered to $17 from $20 at H.C. Wainwright
06/16/22 BMO Capital
Precision BioSciences initiated with an Outperform at BMO Capital
06/09/22 William Blair
Precision BioSciences downgraded to Market Perform at William Blair
12/13/21 BTIG
Precision BioSciences price target raised to $20 from $16 at BTIG
FATE Fate Therapeutics
$20.93 /

+0.1 (+0.48%)

11/16/22 Citi
Fate Therapeutics price target lowered to $80 from $87 at Citi
11/04/22 Cantor Fitzgerald
Fate Therapeutics assumed with an Overweight at Cantor Fitzgerald
10/10/22 Canaccord
Fate Therapeutics initiated with a Buy at Canaccord
08/18/22 Wells Fargo
Fate Therapeutics assumed with an Overweight at Wells Fargo
GILD Gilead
$88.72 /

+0.87 (+0.99%)

07:34 Today Oppenheimer
Gilead price target raised to $105 from $95 at Oppenheimer
11/22/22 Guggenheim
MacroGenics upgraded to Buy at Guggenheim ahead of near-term catalysts
11/09/22 Argus
Gilead price target raised to $100 from $70 at Argus
11/08/22 Cowen
Gilead price target raised to $90 from $80 at Cowen
GRCL Gracell
$3.32 /

+0.07 (+2.15%)

09/22/22 Citi
Gracell initiated with a Buy at Citi
08/18/22 Wells Fargo
Gracell assumed with an Overweight at Wells Fargo
06/01/22 Cantor Fitzgerald
Gracell initiated with an Overweight at Cantor Fitzgerald
05/27/22 Piper Sandler
Gracell price target lowered to $10 from $25 at Piper Sandler
IPSC Century Therapeutics
$10.45 /

-0.02 (-0.19%)

11/14/22 H.C. Wainwright
Century Therapeutics price target lowered to $25 from $27 at H.C. Wainwright
11/11/22 Piper Sandler
Century Therapeutics price target raised to $24 at Piper after R&D day
10/31/22 Guggenheim
Century Therapeutics initiated with a Buy at Guggenheim
10/10/22 Canaccord
Century Therapeutics initiated with a Buy at Canaccord
JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

08:50 Today Jefferies
Horizon Therapeutics price target raised to $125 from $101 at Jefferies
08:42 Today Morgan Stanley
Johnson & Johnson price target raised to $178 from $170 at Morgan Stanley
11/30/22 Wells Fargo
Horizon Therapeutics takeover value could be $135/share, says Wells Fargo
11/29/22 Craig-Hallum
Craig-Hallum sees potential for competing Apollo Endosurgery bids
LEGN Legend Biotech
$51.29 /

-0.035 (-0.07%)

11/02/22 Evercore ISI
Evercore starts Legend Biotech with an Outperform on Carvykti potential
11/01/22 Evercore ISI
Legend Biotech initiated with an Outperform at Evercore ISI
11/01/22 Cowen
Cowen starts Legend Biotech with an Outperform on Carvykti potential
11/01/22 Cowen
Legend Biotech initiated with an Outperform at Cowen
MBIO Mustang Bio
/

+

11/16/22 BTIG
Mustang Bio price target lowered to $4 from $8 at BTIG
08/17/22 BTIG
Bluebird's approval has positive read for Mustang Bio, says BTIG
07/14/22 B. Riley
Mustang Bio price target lowered to $4 from $5 at B. Riley
05/23/22 B. Riley
Mustang Bio price target lowered to $5 from $6 at B. Riley
NKTX Nkarta
$8.43 /

-0.03 (-0.35%)

11/16/22 Mizuho
Nkarta price target lowered to $26 from $81 at Mizuho
11/10/22 Oppenheimer
Nkarta price target lowered to $36 from $50 at Oppenheimer
10/10/22 Canaccord
Nkarta initiated with a Buy at Canaccord
08/12/22 Cantor Fitzgerald
Nkarta price target lowered to $38 from $60 at Cantor Fitzgerald
PSTX Poseida Therapeutics
$4.63 /

+0.09 (+1.98%)

11/11/22 BTIG
Poseida Therapeutics price target lowered to $14 from $20 at BTIG
08/09/22 Piper Sandler
Poseida Therapeutics price target raised to $11 from $9 at Piper Sandler
05/13/22 BTIG
Poseida Therapeutics price target lowered to $20 from $40 at BTIG
05/13/22 Piper Sandler
Poseida Therapeutics price target lowered to $9 from $19 at Piper Sandler
ACET Adicet Bio
$18.31 /

+0.12 (+0.66%)

ACLX Arcellx
$20.08 /

+0.12 (+0.60%)

ALLO Allogene Therapeutics
$9.46 /

-0.38 (-3.86%)

BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

CELU Celularity
$1.78 /

+0.08 (+4.71%)

CLLS Cellectis
$2.22 /

+0.01 (+0.45%)

CRBU Caribou Biosciences
$9.18 /

-0.145 (-1.55%)

CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

DTIL Precision BioSciences
$1.37 /

+0.01 (+0.74%)

FATE Fate Therapeutics
$20.93 /

+0.1 (+0.48%)

GILD Gilead
$88.72 /

+0.87 (+0.99%)

GRCL Gracell
$3.32 /

+0.07 (+2.15%)

IPSC Century Therapeutics
$10.45 /

-0.02 (-0.19%)

JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

MBIO Mustang Bio
/

+

NKTX Nkarta
$8.43 /

-0.03 (-0.35%)

PSTX Poseida Therapeutics
$4.63 /

+0.09 (+1.98%)

  • 04
    Aug
  • 27
    Jul
  • 17
    Jun
  • 26
    Apr
  • 04
    Feb
  • 16
    Dec
  • 08
    Dec
BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

ACET Adicet Bio
$18.31 /

+0.12 (+0.66%)

ACLX Arcellx
$20.08 /

+0.12 (+0.60%)

ALLO Allogene Therapeutics
$9.46 /

-0.38 (-3.86%)

BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

CRBU Caribou Biosciences
$9.18 /

-0.145 (-1.55%)

CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

FATE Fate Therapeutics
$20.93 /

+0.1 (+0.48%)

GILD Gilead
$88.72 /

+0.87 (+0.99%)

GRCL Gracell
$3.32 /

+0.07 (+2.15%)

JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

LEGN Legend Biotech
$51.29 /

-0.035 (-0.07%)

ACLX Arcellx
$20.08 /

+0.12 (+0.60%)

BMY Bristol-Myers
$80.52 /

+0.33 (+0.41%)

CELU Celularity
$1.78 /

+0.08 (+4.71%)

CRSP Crispr Therapeutics
$54.83 /

+0.04 (+0.07%)

GILD Gilead
$88.72 /

+0.87 (+0.99%)

IPSC Century Therapeutics
$10.45 /

-0.02 (-0.19%)

JNJ Johnson & Johnson
$178.00 /

+0.03 (+0.02%)

General news
U.S. ISM manufacturing index dropped -1.2 points to 49.0 in November » 10:20
12/01/22
12/01
10:20
12/01/22
10:20
$ECON

Economic Data

/

+

U.S. ISM manufacturing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Technical Analysis
NASDAQ market internals summary » 10:17
12/01/22
12/01
10:17
12/01/22
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 10:16
12/01/22
12/01
10:16
12/01/22
10:16
$NYE

NYSE Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Options
Blackstone put volume heavy and directionally bearish » 10:15
12/01/22
12/01
10:15
12/01/22
10:15
BX

Blackstone

$86.02 /

-5.43 (-5.94%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$86.02 /

-5.43 (-5.94%)

BX Blackstone
$86.02 /

-5.43 (-5.94%)

11/30/22 Morgan Stanley
Blackstone added to 'Financials' Finest list' at Morgan Stanley
11/22/22 BMO Capital
Blackstone price target lowered to $109 from $115 at BMO Capital
11/22/22 Credit Suisse
Blackstone downgraded to Underperform from Neutral at Credit Suisse
11/15/22 Deutsche Bank
Blackstone price target raised to $128 from $127 at Deutsche Bank
BX Blackstone
$86.02 /

-5.43 (-5.94%)

  • 08
    Dec
BX Blackstone
$86.02 /

-5.43 (-5.94%)

BX Blackstone
$86.02 /

-5.43 (-5.94%)

BX Blackstone
$86.02 /

-5.43 (-5.94%)

Hot Stocks
VICI to acquire remaining 49.9% interest in MGM Grand, Mandalay from BREIT » 10:08
12/01/22
12/01
10:08
12/01/22
10:08
BX

Blackstone

$85.92 /

-5.53 (-6.05%)

, VICI

VICI Properties

$33.85 /

-0.34 (-0.99%)

, MGM

MGM Resorts

$37.29 /

+0.43 (+1.17%)

Blackstone Real Estate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BX Blackstone
$85.92 /

-5.53 (-6.05%)

VICI VICI Properties
$33.85 /

-0.34 (-0.99%)

MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

BX Blackstone
$85.92 /

-5.53 (-6.05%)

11/30/22 Morgan Stanley
Blackstone added to 'Financials' Finest list' at Morgan Stanley
11/22/22 BMO Capital
Blackstone price target lowered to $109 from $115 at BMO Capital
11/22/22 Credit Suisse
Blackstone downgraded to Underperform from Neutral at Credit Suisse
11/15/22 Deutsche Bank
Blackstone price target raised to $128 from $127 at Deutsche Bank
VICI VICI Properties
$33.85 /

-0.34 (-0.99%)

10/24/22 JPMorgan
VICI Properties price target raised to $36 from $35 at JPMorgan
10/12/22 Ladenburg
VICI Properties price target lowered to $34.50 from $36 at Ladenburg
09/19/22 RBC Capital
Gaming and Leisure Properties initiated with an Outperform at RBC Capital
08/24/22 JMP Securities
VICI Properties initiated with an Outperform at JMP Securities
MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

11/28/22 Jefferies
Macau concession renewals removes overhang for incumbents, says Jefferies
11/28/22 JPMorgan
DraftKings downgraded to Underweight from Neutral at JPMorgan
11/21/22 Morgan Stanley
MGM Resorts initiated with an Equal Weight at Morgan Stanley
11/03/22 Deutsche Bank
MGM Resorts price target lowered to $49 from $51 at Deutsche Bank
BX Blackstone
$85.92 /

-5.53 (-6.05%)

VICI VICI Properties
$33.85 /

-0.34 (-0.99%)

MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

  • 04
    Nov
  • 08
    Dec
BX Blackstone
$85.92 /

-5.53 (-6.05%)

MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

BX Blackstone
$85.92 /

-5.53 (-6.05%)

VICI VICI Properties
$33.85 /

-0.34 (-0.99%)

MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

BX Blackstone
$85.92 /

-5.53 (-6.05%)

MGM MGM Resorts
$37.29 /

+0.43 (+1.17%)

Conference/Events
Stifel strategists to hold an analyst/industry conference call » 10:07
12/01/22
12/01
10:07
12/01/22
10:07

Head of Institutional…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Shopify call volume above normal and directionally bullish » 10:05
12/01/22
12/01
10:05
12/01/22
10:05
SHOP

Shopify

$43.51 /

+2.66 (+6.51%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SHOP Shopify
$43.51 /

+2.66 (+6.51%)

SHOP Shopify
$43.51 /

+2.66 (+6.51%)

11/29/22 Jefferies
Shopify BFCM results may point to Q4 tracking ahead of consensus, says Jefferies
11/29/22 UBS
Affirm initiated with a Neutral at UBS
11/15/22 MoffettNathanson
Shopify initiated with a Market Perform at MoffettNathanson
10/28/22 Wells Fargo
Shopify price target raised to $42 from $38 at Wells Fargo
SHOP Shopify
$43.51 /

+2.66 (+6.51%)

SHOP Shopify
$43.51 /

+2.66 (+6.51%)

SHOP Shopify
$43.51 /

+2.66 (+6.51%)

SHOP Shopify
$43.51 /

+2.66 (+6.51%)

General news
November ISM manufacturing index 49.0, consensus 49.9  10:03
12/01/22
12/01
10:03
12/01/22
10:03
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
October construction spending up 9.2% vs. last year  10:02
12/01/22
12/01
10:02
12/01/22
10:02
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

General news
October construction spending down 0.3% vs. last month, consensus down 0.1%  10:02
12/01/22
12/01
10:02
12/01/22
10:02
$ECON

Economic Data

/

+

 
ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Hot Stocks
Goodyear Tire, Nascar enter new multiyear agreement for tires » 10:02
12/01/22
12/01
10:02
12/01/22
10:02
GT

Goodyear Tire

$11.35 /

+0.135 (+1.20%)

The Goodyear Tire &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GT Goodyear Tire
$11.35 /

+0.135 (+1.20%)

GT Goodyear Tire
$11.35 /

+0.135 (+1.20%)

11/29/22 Argus
Goodyear Tire cut to Hold at Argus on EMEA weakness, rising costs
11/29/22 Argus
Goodyear Tire downgraded to Hold from Buy at Argus
11/02/22 Deutsche Bank
Goodyear Tire price target lowered to $10 from $14 at Deutsche Bank
11/02/22 Citi
Goodyear Tire price target lowered to $13 from $16 at Citi
GT Goodyear Tire
$11.35 /

+0.135 (+1.20%)

GT Goodyear Tire
$11.35 /

+0.135 (+1.20%)

GT Goodyear Tire
$11.35 /

+0.135 (+1.20%)

Hot Stocks
Freyr Battery falls -12.7% » 10:00
12/01/22
12/01
10:00
12/01/22
10:00
FREY

Freyr Battery

$11.99 /

-1.65 (-12.10%)

Freyr Battery is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREY Freyr Battery
$11.99 /

-1.65 (-12.10%)

FREY Freyr Battery
$11.99 /

-1.65 (-12.10%)

10/31/22 Cowen
Cowen starts Freyr Battery at Outperform, sees 'less technology risk'
10/31/22 Cowen
Freyr Battery initiated with an Outperform at Cowen
09/21/22 Morgan Stanley
Freyr Battery price target raised to $26, named a 'Top Pick' at Morgan Stanley
09/01/22 BTIG
Freyr Battery price target raised to $25 from $20 at BTIG
FREY Freyr Battery
$11.99 /

-1.65 (-12.10%)

  • 01
    Dec
FREY Freyr Battery
$11.99 /

-1.65 (-12.10%)

FREY Freyr Battery
$11.99 /

-1.65 (-12.10%)

Hot Stocks
One Gas falls -13.5% » 10:00
12/01/22
12/01
10:00
12/01/22
10:00
OGS

One Gas

$75.20 /

-11.7 (-13.46%)

One Gas is down -13.5%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OGS One Gas
$75.20 /

-11.7 (-13.46%)

09:29 Today Guggenheim
One Gas downgraded to Sell at Guggenheim after 'disappointing' five-year plan
07:05 Today Guggenheim
One Gas downgraded to Sell from Neutral at Guggenheim
10/24/22 Guggenheim
One Gas price target lowered to $70 from $86 at Guggenheim
09/22/22 Wells Fargo
One Gas price target lowered to $90 from $98 at Wells Fargo
OGS One Gas
$75.20 /

-11.7 (-13.46%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.